Sterne Kessler
  • Professionals
    View All Professionals
    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Expertise
  • Sterne Kessler AI
Sterne Kessler AI
  • Professionals
  • Expertise
  • News & Insights
  • Events
  • About
  • Careers
  • Visit our Office
  • Subscribe
  • Contact

Insight: Articles

The Federal Circuit Expands Obviousness-Type Double Patenting in Gilead v. Natco.

The DAIMLER Series: Lessons In Personal Jurisdiction for Biologic and Biosimilar Litigants

The DAIMLER Series: Five Personal, Specific Lessons Learned for Hatch-Waxman ANDA Litigants

The DAIMLER Series: District Courts Analyze Personal Jurisdiction in ANDA Cases

The Daimler Confusion And Its Impact On ANDA Litigation

The Curious Case of RPIs & NPEs in IPRs

The Best Offense Is a Good Defense: Patent Prosecution Strategies During Personalized Medicine Drug Development

The Additive Manufacturing Revolution and the Corresponding Legal Landscape

The 1st IPR Institution Decisions For Biosimilars

Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Differing Standards of Appellate Review of Claim Construction

Posts navigation

Older posts
Newer posts

Recent Posts

    Recent Comments

    No comments to show.

    Archives

    No archives to show.

    Categories

    • No categories

    Sterne, Kessler, Goldstein & Fox PLLC

    1101 K Street NW, 10th Floor

    Washington, DC 20005
    (202) 371-2600
    • Professionals
    • Expertise
    • Contact
    • About
    • News & Insights
    • Subscribe
    • Careers
    • Visit our Office
    • Disclaimer
    • Privacy
    • Unsubscribe
    • Sitemap
    © 2026 Sterne, Kessler, Goldstein & Fox PLLC. Attorney advertising; prior results do not guarantee a similar outcome.
    Hit enter to search or ESC to close